THIS END UP RDY 532 (Divalproex Sodium Delayed-Release (Sprinkle) 125 mg)

Pill with imprint THIS END UP RDY 532 is Blue & White, Capsule-shape and has been identified as Divalproex Sodium Delayed-Release (Sprinkle) 125 mg. It is supplied by Dr. Reddy’s Laboratories Inc..

Divalproex sodium is used in the treatment of bipolar disorder; mania; epilepsy; migraine prevention and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 125 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for THIS END UP RDY 532

Divalproex sodium delayed-release (sprinkle) 125 mg THIS END UP RDY 532

Divalproex sodium delayed-release (sprinkle) 125 mg THIS END UP RDY 532 Front

Divalproex Sodium Delayed-Release (Sprinkle)

Imprint: THIS END UP RDY 532
Strength: 125 mg
Color: Blue & White
Size: 19.00 mm
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Fatty acid derivative anticonvulsants
Pregnancy Category: D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine
CSA Schedule: Not a controlled drug
Labeler / Supplier: Dr. Reddy’s Laboratories Inc.
National Drug Code (NDC): 55111-0532
Inactive Ingredients: ferrosoferric oxide, D&C Red No. 28, FD&C Blue No. 1, ethylcelluloses, gelatin, hypromelloses, magnesium stearate, raw sugar, titanium dioxide, triethyl citrate
Note: Inactive ingredients may vary.